Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00696280 · ClinicalTrials.gov registry record
Observational Study of Delayed Nausea and Vomiting
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 106
- Enrollment target
NCT00696280: Completed study, sponsored by Washington University School of Medicine.
NCT00696280 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00696280 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
Delayed emesis following administration of carboplatin-based chemotherapy despite prophylaxis with standard antiemetic prophylaxis (5-HT3 and corticosteroid) remains a clinically significant and distressing problem for patients with cancer. The incidence of delayed emesis appears to be higher in women compared to men.
Primary Outcome
Despite appropriate administration of standard 5-HT3 receptor antagonist antiemetic prophylaxis after the first cycle of chemotherapy.
Interventions
- BEHAVIORAL Functional Living Index - Emesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-11 |
What the finished NCT00696280 record still lists
NCT00696280 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Functional Living Index - Emesis is the first listed.
NCT00696280 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00696280 about?
NCT00696280 is a clinical study titled "Observational Study of Delayed Nausea and Vomiting". Delayed emesis following administration of carboplatin-based chemotherapy despite prophylaxis with standard antiemetic prophylaxis (5-HT3 and corticosteroid) remains a clinically significant and distressing problem for patients with cancer. The incidence of delayed emesis appears to be higher in wom...
What is the current status of trial NCT00696280?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2006-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00696280?
The interventions under investigation include: Functional Living Index - Emesis (BEHAVIORAL).
Who is sponsoring clinical trial NCT00696280?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia